[HTML][HTML] N6-methyladenosine (m6A) in pancreatic cancer: Regulatory mechanisms and future direction

J Li, F Wang, Y Liu, H Wang, B Ni - International Journal of …, 2021 - ncbi.nlm.nih.gov
Abstract N 6-methyladenosine (m 6 A), the most abundant RNA modification in eukaryotes,
plays a pivotal role in regulating many cellular and biological processes. Aberrant m 6 A …

[HTML][HTML] Role of N6-methyladenosine in the pathogenesis, diagnosis and treatment of pancreatic cancer

T Ye, J Wang, H Zhao, G Zhao… - … Journal of Oncology, 2022 - spandidos-publications.com
Pancreatic cancer (PC) ranks as the seventh leading cause of cancer-associated mortality,
and is predicted to become the third leading cause of cancer-associated mortality by the …

[HTML][HTML] The role of m6A RNA methylation in cancer

T Sun, R Wu, L Ming - Biomedicine & Pharmacotherapy, 2019 - Elsevier
Abstract N6-methyladenosine (m6A), the most abundant internal modification of RNA in
eukaryotic cells, has gained increasing attention in recent years. The m6A modification …

[HTML][HTML] Mechanism of RNA modification N6-methyladenosine in human cancer

Z Zhou, J Lv, H Yu, J Han, X Yang, D Feng, Q Wu… - Molecular cancer, 2020 - Springer
Since the breakthrough discoveries of DNA and histone modifications, the field of RNA
modifications has gained increasing interest in the scientific community. The discovery of N6 …

Regulation of gene expression by N6-methyladenosine in cancer

J Liu, BT Harada, C He - Trends in cell biology, 2019 - cell.com
As the most abundant mRNA modification in eukaryotic cells, N 6-methyladenosine (m 6 A)
has recently emerged as an important regulator of gene expression. m 6 A modification can …

[HTML][HTML] N6-Methyladenosine: A Novel RNA Imprint in Human Cancer

S Yu, X Li, S Liu, R Yang, X Liu, S Wu - Frontiers in oncology, 2019 - frontiersin.org
N6-Methyladenosine (m6A), a pervasive posttranscriptional modification which is reversible,
has been among hotspot issues in the past several years. The balance of intracellular m6A …

[HTML][HTML] Emerging roles of N6-methyladenosine (m6A) modification in breast cancer

Y Wang, Y Zhang, Y Du, M Zhou, Y Hu, S Zhang - Cell & Bioscience, 2020 - Springer
Abstract N 6-Methyladenosine (m 6 A) is the most abundant, dynamic, and reversible
epigenetic RNA modification that is found in coding and non-coding RNAs. Emerging …

N6‐methyladenosine Steers RNA Metabolism and Regulation in Cancer

S Dong, Y Wu, Y Liu, H Weng… - Cancer …, 2021 - Wiley Online Library
As one of the most studied ribonucleic acid (RNA) modifications in eukaryotes, N6‐
methyladenosine (m6A) has been shown to play a predominant role in controlling gene …

[HTML][HTML] The emerging roles of N6-methyladenosine (m6A) deregulation in liver carcinogenesis

M Chen, CM Wong - Molecular cancer, 2020 - Springer
Liver cancer is a common cancer worldwide. Although the etiological factors of liver
carcinogenesis are well defined, the underlying molecular mechanisms remain largely …

[HTML][HTML] The m6A-related mRNA signature predicts the prognosis of pancreatic cancer patients

Z Meng, Q Yuan, J Zhao, B Wang, S Li… - Molecular Therapy …, 2020 - cell.com
N 6-methyladenosine (m 6 A) has an important epitranscriptomic modification that controls
cancer self-renewal and cell fate. The addition of m 6 A to mRNA is a reversible modification …